Showing results (1411-1420 of 4,565) with videos related to

Sort By:
Pageof 457
Advances in Therapy|August 11, 2021
Prognostic Score System Using Preoperative Inflammatory, Nutritional and Tumor Markers to Predict Prognosis for Gastric Cancer: A Two-Center Cohort StudyHuayang Pang, Weihan Zhang, Xianwen Liang, et al.
Advances in Therapy|August 13, 2021
Long-Term Safety and Effectiveness of Thyrotropin Alfa in Japanese Patients: A Post-Marketing Surveillance StudyRie Kanamori, Shiho Yamane, Takeshi Seto
Advances in Therapy|August 9, 2021
Long-Term Disease Stability Assessed by the Expanded Disability Status Scale in Patients Treated with Cladribine Tablets 3.5 mg/kg for Relapsing Multiple Sclerosis: An Exploratory Post Hoc Analysis of the CLARITY and CLARITY Extension StudiesGavin Giovannoni, Giancarlo Comi, Kottil Rammohan, et al.
Advances in Therapy|August 10, 2022
Identification of Metastasis-Associated Genes in Cutaneous Squamous Cell Carcinoma Based on Bioinformatics Analysis and Experimental ValidationLang Chen, Xuan Liao, Xiao Jiang, et al.
Advances in Therapy|August 10, 2022
Characterizing the Shifting Real-World Treatment Landscape by PD-L1 Testing Status and Expression Level in Advanced Non-Small Cell Lung CancerWenzhen Ge, Ning Wu, Ruben G W Quek, et al.
Advances in Therapy|August 11, 2022
New Perspectives on Micronised Purified Flavonoid Fraction in Chronic Venous Disease: From Microvalves to Clinical EffectivenessEliete Bouskela, Marzia Lugli, Andrew Nicolaides
Advances in Therapy|May 4, 2020
Persistence and Adherence to ICS/LABA Drugs in UK Patients with Asthma: A Retrospective New-User Cohort StudyMounika Parimi, Henrik Svedsater, Quratul Ann, et al.
Advances in Therapy|May 4, 2020
Advances in Clinical Cardiology 2019: A Summary of Key Clinical TrialsKatie Linden, Jonathan Mailey, Aileen Kearney, et al.
Advances in Therapy|May 8, 2021
Use of Non-Vitamin K Antagonist Oral Anticoagulants Among Patients with Nonvalvular Atrial Fibrillation and MultimorbiditySteven Deitelzweig, Allison Keshishian, Amiee Kang, et al.
Advances in Therapy|May 8, 2021
A Randomized Phase 1 Safety, Pharmacokinetic and Pharmacodynamic Study of the Novel Myostatin Inhibitor Apitegromab (SRK-015): A Potential Treatment for Spinal Muscular AtrophyDoreen Barrett, Sanela Bilic, Yung Chyung, et al.
Pageof 457